Clinical Social Workers in Sandy, OR Accepting Medicare
5 Clinical Social Workers found. Showing 1 - 5
 Christopher J Robb, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 38872 Proctor Blvd, Sandy, OR 97055 Phone: 503-722-6950 |
 Deborah L Mccarter, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 38872 Proctor Blvd, Sandy, OR 97055 Phone: 503-722-6950 Fax: 503-668-5593 |
Mr. Dustin Jay Lawrence Baldwin, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 38872 Proctor Blvd, Sandy, OR 97055 Phone: 503-722-6950 Fax: 503-722-6939 |
Joanne E Serna, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 38961 Pioneer Blvd, Sandy, OR 97055 Phone: 503-740-1555 Fax: 503-740-1555 |
Ms. Judy Dianne Jensen, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 53755 E Terra Fern Dr, Sandy, OR 97055 Phone: 503-826-1063 Fax: 503-826-1063 |
News Archive
H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus
The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. "In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing," the agency said. "Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island," the news service writes (Nebehay, 11/6).
Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology
The intention of the Medical Innovation Bill is to encourage and support doctors to explore new medicines for their patients when they believe existing options are no longer achieving good outcomes.
Beckman Coulter Releases Compact DxH 500 Hematology System with CE Mark
Beckman Coulter Diagnostics has released the DxH 500 haematology system with CE Mark, an open-vial instrument offering a throughput of up to 60 samples per hour.
Pembrolizumab (Keytruda) effective in patients with recurrent or metastatic head and neck cancer
Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology.
Targacept reports net loss of $11.6M in first quarter 2014
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2014.
› Verified 4 days ago